Correction: Colorectal carcinoma peritoneal metastases­derived organoids: results and perspective of a model for tailoring hyperthermic intraperitoneal chemotherapy from bench­to­bedside.

Varinelli, Luca; Battistessa, Davide; Guaglio, Marcello; Zanutto, Susanna; Illescas, Oscar; Lorenc, Ewelina J; Pisati, Federica; Kusamura, Shigeki; Cattaneo, Laura; Sabella, Giovanna; Milione, Massimo; Perbellini, Alessia; Noci, Sara; Paolino, Cinzia; Kuhn, Elisabetta; Galassi, Margherita; Cavalleri, Tommaso; Deraco, Marcello; Gariboldi, Manuela; Baratti, Dario

Correction: Colorectal carcinoma peritoneal metastasesderived organoids: results and perspective of a model for tailoring hyperthermic intraperitoneal chemotherapy from benchtobedside.

Varinelli, Luca; Battistessa, Davide; Guaglio, Marcello; Zanutto, Susanna; Illescas, Oscar; Lorenc, Ewelina J; Pisati, Federica; Kusamura, Shigeki; Cattaneo, Laura; Sabella, Giovanna; Milione, Massimo; Perbellini, Alessia; Noci, Sara; Paolino, Cinzia; Kuhn, Elisabetta; Galassi, Margherita; Cavalleri, Tommaso; Deraco, Marcello; Gariboldi, Manuela; Baratti, Dario.

Afiliación

Varinelli L; Department of Experimental Oncology, Molecular Epigenomics Unit, Fondazione IRCCS Istituto Nazionale Tumori, Via G. Venezian 1, Milan, 20133, Italy.
Battistessa D; Department of Experimental Oncology, Molecular Epigenomics Unit, Fondazione IRCCS Istituto Nazionale Tumori, Via G. Venezian 1, Milan, 20133, Italy.
Guaglio M; Peritoneal Surface Malignancies Unit, Colorectal Surgery, Fondazione IRCCS Istituto Nazionale Tumori, Via G. Venezian 1, Milan, 20133, Italy.
Zanutto S; Department of Experimental Oncology, Molecular Epigenomics Unit, Fondazione IRCCS Istituto Nazionale Tumori, Via G. Venezian 1, Milan, 20133, Italy.
Illescas O; Department of Experimental Oncology, Molecular Epigenomics Unit, Fondazione IRCCS Istituto Nazionale Tumori, Via G. Venezian 1, Milan, 20133, Italy.
Lorenc EJ; Department of Experimental Oncology, Molecular Epigenomics Unit, Fondazione IRCCS Istituto Nazionale Tumori, Via G. Venezian 1, Milan, 20133, Italy.
Pisati F; Cogentech Ltd. Benefit Corporation With a Sole Shareholder, Via Adamello 16, Milan, 20139, Italy.
Kusamura S; Peritoneal Surface Malignancies Unit, Colorectal Surgery, Fondazione IRCCS Istituto Nazionale Tumori, Via G. Venezian 1, Milan, 20133, Italy.
Cattaneo L; Pathology and Laboratory Medicine Department, Fondazione IRCCS Istituto Nazionale Dei Tumori Di Milano, Via G. Venezian 1, Milan, 20133, Italy.
Sabella G; Pathology and Laboratory Medicine Department, Fondazione IRCCS Istituto Nazionale Dei Tumori Di Milano, Via G. Venezian 1, Milan, 20133, Italy.
Milione M; Pathology and Laboratory Medicine Department, Fondazione IRCCS Istituto Nazionale Dei Tumori Di Milano, Via G. Venezian 1, Milan, 20133, Italy.
Perbellini A; Department of Experimental Oncology, Molecular Epigenomics Unit, Fondazione IRCCS Istituto Nazionale Tumori, Via G. Venezian 1, Milan, 20133, Italy.
Noci S; Department of Experimental Oncology, Molecular Epigenomics Unit, Fondazione IRCCS Istituto Nazionale Tumori, Via G. Venezian 1, Milan, 20133, Italy.
Paolino C; Department of Experimental Oncology, Molecular Epigenomics Unit, Fondazione IRCCS Istituto Nazionale Tumori, Via G. Venezian 1, Milan, 20133, Italy.
Kuhn E; Department of Biomedical, Surgical and Dental Sciences, University of Milan, Milan, 20122, Italy.
Galassi M; Pathology Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, 20122, Italy.
Cavalleri T; Centrale Produzione Farmaci, Hospital Pharmacy, Fondazione IRCCS Istituto Nazionale Dei Tumori Di Milano, Via G. Venezian 1, Milan, 20133, Italy.
Deraco M; Peritoneal Surface Malignancies Unit, Colorectal Surgery, Fondazione IRCCS Istituto Nazionale Tumori, Via G. Venezian 1, Milan, 20133, Italy.
Gariboldi M; Peritoneal Surface Malignancies Unit, Colorectal Surgery, Fondazione IRCCS Istituto Nazionale Tumori, Via G. Venezian 1, Milan, 20133, Italy. marcello.deraco@istitutotumori.mi.it.
Baratti D; Department of Experimental Oncology, Molecular Epigenomics Unit, Fondazione IRCCS Istituto Nazionale Tumori, Via G. Venezian 1, Milan, 20133, Italy.

J Exp Clin Cancer Res ; 43(1): 162, 2024 Jun 11.

Article en En | MEDLINE | ID: mdl-38862991

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: J Exp Clin Cancer Res Año: 2024 Tipo del documento: Article País de afiliación: Italia